Multicenter Observational study to evaluate the effectiveness of a biosimilar Etanercept (ErelziTM) in patients with established Rheumatic disease previously treated with reference etanercept. (BRONZE)

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Effectiveness study (incl. comparative)

Non-interventional study

• Non-interventional study design:
  Other
• Non-interventional study design, other:
  National, Multicenter, Prospective, Post-Authorization, non-PASS, Real Life, Observational Study.

Study drug and medical condition

• Medicinal product name:
  ERELZI

Population studied

• Age groups:
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)
• Estimated number of subjects:
  650

Study design details

• Main study objective:
  To evaluate effectiveness of ErelziTM in patients with RA, AS or PsA with, stable clinical response to Enbrel®.
• Data analysis plan:
  No minimum number of patients in each disease indication will be required.